Seagen to highlight data from expanding oncology portfolio at 2022 american society of clinical oncology (asco) annual meeting

Bothell, wash.--(business wire)--seagen inc. (nasdaq:sgen) today announced upcoming presentations of new data from its expanding pipeline of marketed and investigational therapies at the 2022 american society of clinical oncology (asco) annual meeting, to be held june 3-7, 2022 in chicago. the accepted abstracts demonstrate the growth of seagen's portfolio and clinical progress across multiple cancer types, including cervical and urothelial cancers and pediatric and adult hodgkin lymphoma. grou
SGEN Ratings Summary
SGEN Quant Ranking